The PortiVix platform
One operating model for pharma portfolio decisions and project execution.
PortiVix connects the commercial view of molecules and portfolios with the execution view of projects, workstreams, tasks, resources, materials, risks, issues, reports, and audit evidence.
The command centre
Portfolio health and pipeline value, in one live view.
Leadership sees eNPV, at-risk molecules, and phase movement without waiting for a status pack, the same governed record that delivery teams work in every day.

Two connected hierarchies
Leadership thinks in portfolios. Delivery teams work in projects. PortiVix connects both.
Pharma organisations need both views, without forcing teams into one flat project structure. Leadership thinks in portfolios, molecules, phase gates, risk, and value. Delivery teams work through projects, workstreams, tasks, dependencies, resources, and approvals.
Commercial / molecule hierarchy
Execution hierarchy
TenantOrganisation
Your isolated, configured environment.
PortfolioPipeline view
Leadership view of pipeline health and value.
ProgrammeGrouped assets
Related molecules by indication, stage, or objective.
MoleculeAsset record
Commercial, patent, phase, risk, financial, and decision history.
Phase / TaskProgress
Planned, estimated, actual, and latest best estimate (LBE) dates.
TenantOrganisation
Same governed boundary as the commercial view.
PortfolioDelivery view
Portfolio-level Gantt across projects.
ProjectExecution plan
Structured, template-driven, and governed.
WorkstreamDepartment delivery
R&D, analytical development (ADL), RA, QA, manufacturing, supply, commercial.
MilestoneGate
Critical path indicators and roll-up.
TaskOwned work
Approvals, comments, @mentions, documents.
SubTaskBreakdown
Detailed decomposition of a task.
ActivityAtomic step
Where progress is captured first.
Project execution
Milestone to activity, with critical path, risks, and issues.
Delivery teams work the same governed record leadership sees, a structured plan of milestones, tasks, and subtasks, with dependencies, critical path, a project risk register, and an issue tracker.

Governance roll-up
Task-level progress becomes portfolio visibility.
Progress captured at the activity level rolls up through workstreams and projects into programme and portfolio views, and leadership decisions flow back down into governed execution.
Task update
owner marks progress
Shown: Project plan, Excipient compatibility task
Workstream progress
department roll-up
Shown: Project plan, Formulation development workstream
Project health
milestones & critical path
Shown: Project plan, health and completion
Programme risk
cross-molecule view
Shown: Risk Control Tower, Risk heatmap
Portfolio dashboard
leadership visibility
Shown: My Dashboard, Portfolio KPIs
Inside the model
Five levels, one connected record.
-
Level 01, Portfolio
Portfolio, executive command across programmes, molecules, projects, risk, and value.
The leadership view of pipeline health: active molecules, programmes, projects, milestones, risks, issues, financial metrics, and resource pressure, without waiting for a manually assembled pack.
- 01Portfolio-level Gantt across projects
- 02Command Centre with molecule, project, risk, and financial indicators
- 03Configurable discovery and access modes
- 04Portfolio trends and historical performance
- 05Named owner accountability and audit trail
-
Level 02, Programme
Programme, group assets around the decisions leadership needs to make.
Programmes group related molecules by indication, lifecycle stage, commercial objective, or therapeutic area, surfacing what is moving, blocked, or needs escalation before it becomes a portfolio surprise.
- 01Programme manager ownership
- 02Status visibility across linked molecules and projects
- 03PMO governance reporting
- 04Cross-programme milestone and risk tracking
-
Level 03, Molecule
Molecule, every asset, every assumption, every decision record.
The single source of truth for the asset: pharma classification, commercial assumptions, patent and regulatory fields, phase gates, PTRS and risk scores, NPV/eNPV, materials, documents, snapshots, and decision commentary.
- 01Manual creation or Portfolio Builder import from public FDA data
- 02Commercial metrics: market size, revenue at launch, peak revenue, kill threshold
- 03Patent expiry tracking: DS, DP, and AoP
- 04Phase management: planned, estimated, actual, and latest best estimate (LBE) dates
- 05Snapshots and baselines for before-and-after comparisons
-
Level 04, Project
Project, governed execution from milestone to activity.
Structured plans with milestones, tasks, subtasks, activities, dependencies, critical path indicators, approvals, comments, documents, risks, issues, and template-driven setup.
- 01Four-level plan: Milestone → Task → SubTask → Activity
- 02Dependencies: FS, SS, FF, and SF with lag days
- 03Interactive Gantt and portfolio-level Gantt
- 04Template lock mechanics for governed project plans
- 05Approval queue, comments, @mentions, documents, activity feed
-
Level 05, Workstream
Workstream, cross-functional delivery, visible by department.
Workstreams coordinate R&D, analytical development laboratory (ADL), formulation, regulatory, QA/QC, manufacturing, supply chain, and commercial functions, each with department ownership, milestones, tasks, progress, and escalation paths.
- 01Department-linked workstreams
- 02Named workstream owners
- 03Reorderable milestones and critical path indicators
- 04Progress roll-up into project and portfolio views
- 05Workstream Progress report





Shown: PMO Governance
See the operating model mapped to your pipeline.
We do not start with a generic demo. We map your portfolio, molecule, project, approval, reporting, and governance workflows first, then show how PortiVix would work for your organisation.
Or write to marketing@virtunx.com

